Aigen Investment Management’s Eli Lilly LLY Stock Holding History

Aigen Investment Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.32M	Sell	1,102 -969	-47%	-$990K	0.36%	78
2026 Q1	$1.9M	Buy	+2,071	New	+$2.1M	0.49%	54
2025 Q3	–	Sell	-792	Closed	-$617K	–	954
2025 Q2	$617K	Buy	+792	New	+$615K	0.08%	345
2024 Q4	–	Sell	-1,618	Closed	-$1.43M	–	882
2024 Q3	$1.43M	Buy	+1,618	New	+$1.45M	0.28%	88
2024 Q2	–	Sell	-8,520	Closed	-$6.63M	–	919
2024 Q1	$6.63M	Buy	+8,520	New	+$6.06M	1.44%	1
2022 Q3	–	Sell	-4,693	Closed	-$1.52M	–	681
2022 Q2	$1.52M	Sell	4,693 -5,840	-55%	-$1.75M	0.26%	118
2022 Q1	$3.02M	Buy	10,533 +3,696	+54%	+$951K	0.52%	48
2021 Q4	$1.83M	Buy	+6,837	New	+$1.73M	0.11%	240
2021 Q2	–	Sell	-2,724	Closed	-$509K	–	618
2021 Q1	$509K	Buy	+2,724	New	+$533K	0.07%	287
2020 Q4	–	Sell	-6,586	Closed	-$975K	–	921
2020 Q3	$975K	Buy	+6,586	New	+$1.02M	0.12%	258
2020 Q2	–	Sell	-5,251	Closed	-$728K	–	1087
2020 Q1	$728K	Buy	+5,251	New	+$721K	0.1%	303

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aigen Investment Management's LLY Position: Q2 2026 in Review

Aigen Investment Management reduced its Eli Lilly (LLY) stake by 47% in Q2 2026, selling an estimated $990K and leaving 1,102 shares worth $1.32M. The position accounts for 0.36% of the portfolio, ranked #78.

Aigen Investment Management first reported a position in LLY in Q1 2020 and has held it in 11 quarters since. The position peaked at $6.63M in Q1 2024. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Aigen Investment Management held 1,102 shares of Eli Lilly worth $1.32M as of Q2 2026.
Aigen Investment Management sold 969 Eli Lilly shares in Q2 2026, an estimated $990K.
Eli Lilly made up 0.36% of Aigen Investment Management's portfolio in Q2 2026, its #78 holding.
Aigen Investment Management first reported a position in Eli Lilly in Q1 2020 and has held it in 11 quarters since.
Aigen Investment Management's Eli Lilly position peaked at $6.63M in Q1 2024.
4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.